A new definition of Alzheimer's disease: a hippocampal dementia.
about
Regulation of the Postsynaptic Compartment of Excitatory Synapses by the Actin Cytoskeleton in Health and Its Disruption in DiseaseOpposite monosynaptic scaling of BLP-vCA1 inputs governs hopefulness- and helplessness-modulated spatial learning and memoryIsolation and chemical characterization of Alzheimer's disease paired helical filament cytoskeletons: differentiation from amyloid plaque core proteinMagnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.Molecular insights into Alzheimer's disease.Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.Protective effects of compound FLZ on beta-amyloid peptide-(25-35)-induced mouse hippocampal injury and learning and memory impairment.Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease.Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.Anterior-posterior cerebral blood volume gradient in human subiculum.The search for early markers of AD: hippocampal atrophy and memory deficits.Autism as a sequence: from heterochronic germinal cell divisions to abnormalities of cell migration and cortical dysplasiasThe diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.Annual research review: progress in using brain morphometry as a clinical tool for diagnosing psychiatric disorders.Amyloid burden in cognitively normal elderly is associated with preferential hippocampal subfield volume loss.Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squaresMaternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolismHypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaintsRecent advances in the understanding of dementiaHippocampal hypometabolism predicts cognitive decline from normal aging.Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer's disease and mild cognitive impairment.Effects of aluminum on the reduction of neural stem cells, proliferating cells, and differentiating neuroblasts in the dentate gyrus of D-galactose-treated mice via increasing oxidative stressBlood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly.Impact of SORL1 genetic variations on MRI markers in non-demented elders.Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles.FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's diseasePrevalence of hippocampal morphologic variants between healthy elderly subjects and patients with Alzheimer's disease.Structural magnetic resonance imaging-derived biomarkers for Alzheimer's disease.The Role of Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Cognition.Which presidents are most memorable?Representation of semantic and spatial knowledge in Alzheimer's patients: implications for models of preserved learning in amnesia.Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer.Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome.The cortical dementias.[18F]FDG-PET in patients with Alzheimer's disease: marker of disease spread.In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease.Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease.Rational drug treatment of dementia?Partial volume correction for PET quantification and its impact on brain network in Alzheimer's disease.Emergence of spatial impairment in rats following specific cholinergic depletion of the medial septum combined with chronic stress.
P2860
Q26748973-23F8FB48-A4F2-4026-9980-7FB7CD9F010CQ27342812-CFC0C8C2-DCE4-4519-B324-88ACD78DCD64Q28760169-857F3BA6-3941-44C8-A79A-448DB996FFC6Q30988163-A4B73A37-9D41-4387-80DA-E2A86DABA423Q31058930-083371D2-8581-4704-BE0F-4920C09D39B8Q31108280-C60EE3A3-C801-47AB-B0D7-EFC6F13651B0Q33244612-86D5AD95-C6BB-44E2-ABD3-30CD846A120FQ33554847-6107AF50-0743-4C35-BAA0-C77A065421DFQ33591798-BA5A52EA-68E6-4B32-A224-AE1552923B1FQ33688290-A5121C55-D243-4A89-AD8A-CCD445386316Q33709852-BA686B48-E531-430B-889E-C2C48636287EQ33803711-C2164B44-70F5-4190-8209-B52EE658C760Q34460995-4D0C89AB-2CAA-4A98-BBDF-C0757303A407Q34532241-23C8718A-B9C6-44A7-B2A3-603AD82B6B70Q35152147-538CCEB6-FAE4-4FD8-8AA0-9C5F1B2A31AFQ35887041-B87E690D-772F-4832-BDAB-E9808D698C1AQ36277213-E01D90CF-3C58-440E-B1B6-4F84510CB898Q36661066-51270C92-43A1-4907-ACF3-5C2139FAFFA4Q36722253-09B9BA15-F352-46E9-9099-131EAB0C97EAQ36725261-626C5092-9986-468F-B3F4-3C550E203CE7Q36773815-AF55F76C-1C20-44FF-AFD7-A2C5016D88DFQ37039462-C4FB646A-3DB7-4ED3-B9E2-785ED2F8A60AQ37237593-23887186-F1AD-4248-A36B-EBFDE99FDADDQ37362490-068658C3-4BBD-4812-9C73-85BDF514F1ADQ37383448-1095AEA1-10C8-4176-BFC1-E4686B4698AAQ37415324-C031B7DD-F68F-413C-B829-C452AA1B34B6Q37632029-703C77B2-4AE1-4FFB-97DD-193BC85E32CEQ37755134-104A10B4-8C13-4D63-BBD6-D743DEEBFAD9Q37921617-F6F39F09-51B6-470B-B765-6D514768AB48Q38389147-61DD6993-C8C4-4414-9DE7-252E0961B9B6Q38489485-0B798F5C-DBC4-45D7-9D0E-58914109DE5AQ38665015-404D8BC0-E611-4754-86A0-37719FBFEDA8Q39480888-F47D2923-397C-4D58-9FF7-32D5A2502942Q39554675-E7D5B966-5185-444D-99C2-47AA6F9B290FQ40480799-460283E5-AFA2-4240-BF40-84A29BAE433EQ40952455-36562EAD-DA5E-4922-954F-4EF40E0496D2Q41605276-B861EBAB-D86F-42ED-8D18-884C0DFCC1E6Q41947934-3D7B437C-9CD4-45E0-B1AD-3457EB69BCACQ42376086-25F6703F-C227-4A4E-BD68-E8DBBA5641FBQ42435435-01686405-EDF1-4C09-B0D5-B9A6743443A7
P2860
A new definition of Alzheimer's disease: a hippocampal dementia.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
A new definition of Alzheimer's disease: a hippocampal dementia.
@en
type
label
A new definition of Alzheimer's disease: a hippocampal dementia.
@en
prefLabel
A new definition of Alzheimer's disease: a hippocampal dementia.
@en
P2093
P1433
P1476
A new definition of Alzheimer's disease: a hippocampal dementia.
@en
P2093
A J Kirshen
V Hachinski
P356
10.1016/S0140-6736(85)90965-1
P407
P577
1985-01-01T00:00:00Z